From GlobeNewswire: 2025-02-14 17:15:40

Codexis, Inc. announced equity grants to five new employees, consisting of options to purchase 39,000 shares and 27,500 restricted stock units. The stock options have an exercise price based on Nasdaq’s closing price and vest over four years. The RSUs will vest annually until the third anniversary. Codexis is a leading provider of enzymatic solutions for therapeutics manufacturing, using its CodeEvolver® technology platform. The company is developing an ECO Synthesis™ platform for scaled RNAi therapeutics manufacture. For more information, visit www.codexis.com. Contact Carrie McKim at (336) 608-9706 for investor inquiries and Lauren Musto at (650) 421-8205 for media inquiries.



Read more at GlobeNewswire: Codexis Announces New Employment Inducement Grants